PEStore

Family Office

Cambridge Capital.

Cambridge Capital. invests a family's own capital, often with no fixed holding period, from South Africa. It states a focus on healthcare & life sciences, consumer & retail and industrials & manufacturing.

Capital raised$109macross 9 SEC-filed vehicles
Most recent fund2022filing since 2015
HeadquartersSouth Africa
Largest single fund$38m

Stated investment criteria

What Cambridge Capital. says it buys

Read from Cambridge Capital.’s own website in August 2026. This is what the firm says it buys, not what anyone has recorded it buying, and figures are shown in the currency the firm itself used - nothing here is converted. Every line links to the page it was read from.

Transaction typesPlatform, Add-on1
Founded20151

A stated mandate is a firm’s description of itself and was true of the page on the day it was read; firms widen and narrow what they will look at without updating the site. Nothing here is a commitment by Cambridge Capital. to consider any particular business, and nothing on this page is represented as being for sale.

SEC filings

What Cambridge Capital. has raised

From this firm's own Form D filings. A fund files one within fifteen days of its first sale, under penalty of perjury, which makes these the hardest numbers on the page.

Vehicles filed9
Total capital raised$109m
Largest single vehicle$38m
Filing history2015 to 2022
Smallest accepted commitment$25k
Filed fromFLORIDA

Form D covers US-domiciled vehicles raised from accredited investors. It will not capture a fund raised outside the United States, separately managed accounts, or capital deployed off balance sheet, so treat these as a floor rather than a total.

Regulatory record

How Cambridge Capital. is registered

From this firm's Form ADV, the annual filing every registered and exempt investment adviser makes to the SEC.

Adviser statusSEC registered
Regulatory assets under management$458m
Employees5
SEC adviser numberCRD 110932

Valuation context

Transaction values in Healthcare & Life Sciences

What companies have actually sold for in healthcare & life sciences, across 1,263 recorded transactions.

Median consideration$110m
Middle 50%$30m-$318m
Revenue multiple2.8×
EBITDA multiple12.5×

The full healthcare & life sciences picture - most active acquirers, recent transactions and every investor in the sector.

For owners

Own a healthcare & life sciences business?

The investors on this page acquire companies like yours. A confidential valuation costs nothing, commits you to nothing, and nobody is told you asked.

Request a confidential valuation

For investors

Is this Cambridge Capital.?

Claim this profile to correct anything wrong and tell us what you are looking for. We will send matching opportunities as they arise.

Claim or correct this profile

Targeted buyer search

Which hundred of these would actually buy your business?

A researched shortlist with a verified deal-team contact for each, and the reason it is on the list. Fixed fee, from $1,450 - or we make the approach for you and hand you the conversations.

See how it works

Comparable investors

Similar mandates

Other family office investors active in healthcare & life sciences.